The main objective of this study was to determine the precise frequency of chromosome 14q loss of heterozygosity in nasopharyngeal carcinomas and to define its minimal deletion regions. Thirty-nine tumors were selected for PCRbased deletion mapping using 19 microsatellite polymorphic markers spannin
Loss of heterozygosity for chromosome 14q in neuroblastoma
β Scribed by Thompson, P.M. ;Seifried, B.A. ;Kyemba, S.K. ;Jensen, S.J. ;Guo, C. ;Maris, J.M. ;Brodeur, G.M. ;Stram, D.O. ;Seeger, R.C. ;Gerbing, R. ;Matthay, K.K. ;Matise, T.C. ;White, P.S.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 133 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
One of the main genetic abnormalities associated with breast carcinogenesis is the loss of genetic material from chromosome arm 16q. Different groups have identified two regions (16q22.1 and 16q24-ter) that are frequently deleted in primary tumors, suggesting the presence of tumor suppressor genes i
We have examined a series of 24 Merkel cell carcinoma (MCC) DNAs for loss of heterozygosity (LOH) at eight loci on chromosome 13. All patients were heterozygous for at least one locus. Overall, 18 of 24 (75%) patients showed LOH, among whom 10 patients demonstrated LOH at all informative loci. A sin
We examined 88 nonpapillary renal cell carcinomas for allelic loss at chromosome arm 14q and correlated the results to size, grade, and stage of these tumors. Fourteen highly polymorphic microsatellite markers on the long arm of chromosome 14 were used for deletion mapping. Loss of heterozygosity (L
Forty-four breast carcinomas were studied for loss of heterozygosity (LOH) at 25 microsatellite markers distributed almost evenly along chromosome arm 22q. LOH at at least one marker were observed in 66% tumors, while 6 regions of consistent LOH were identified. The size of each region ranged betwee